Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Shield Bio
AddedFeb 15, 2024
UpdatedJul 3, 2026
Shield Bio

Shield Bio

Closed

Shield Bio: Fast, precise nanopore sequencing for healthcare, targeting infectious diseases and antibiotic resistance.

HQ
San Jose, CA, US
Founded
2016
Accelerator
Y Combinator logoY CombinatorS16
Overview
Compare
Fundraising
Employees

Shield Bio is a precision medicine company with arnproprietary platform that enables reliable nanoporernsequencing in under a minute, in a clinical setting. It isrnfocused on bringing 3rd generation or "nanopore"rnsequencing into clinical use to deliver on the promise ofrnprecision medicine.

Shield is initially using the technology tornimprove the treatment of infectious disease and address thernunmet clinical need of sepsis, which kills 300,000 people arnyear in the US alone.

Shield Bio - Similar Companies

Nano Cures logo

Nano Cures

nanocures.com

INanoBio logo

INanoBio

inanobio.com

PathoGene logo

PathoGene

Delve Bio logo

Delve Bio

delve.bio

BioAmp diagnostics logo

BioAmp diagnostics

bioampdx.com

Biotia logo

Biotia

biotia.io

Aperiomics logo

Aperiomics

Felix Biotechnology logo

Felix Biotechnology

Sequegenics logo

Sequegenics

sequegenics.com

PhagePro logo

PhagePro

phageproinc.com

Bioinfoexperts logo

Bioinfoexperts

bioinfox.com

Seer logo

Seer

seer.bio

Biomiic logo

Biomiic

Mission Bio logo

Mission Bio

OmniVis logo

OmniVis

Shield Bio - Quick Facts

Who are Shield Bio's competitors?

Companies similar to Shield Bio include Nano Cures, INanoBio, PathoGene and Delve Bio.

When was Shield Bio founded?

Shield Bio was founded in 2016.

Where is Shield Bio's headquarters located?

Shield Bio's headquarters is located in San Jose, CA, US.

How much has Shield Bio raised to-date?

As of Apr 1, 2019, Shield Bio has raised a total of $12.1M (USD).

Shield Bio - Classification

Ownership
  • Venture Capital
Technology
  • Analytics
  • Biotech
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Tags
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 9 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified